Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amplifon Earnings Release 2022

May 3, 2022

4030_10-q_2022-05-03_74ed0c66-91e3-4e5b-ab64-6187b1fe7706.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Informazione
Regolamentata n.
0525-34-2022
Data/Ora Ricezione
03 Maggio 2022
12:55:49
Euronext Star Milan
Societa' : AMPLIFON
Identificativo
Informazione
Regolamentata
: 161503
Nome utilizzatore : AMPLIFONN01 - Galli
Tipologia : REGEM
Data/Ora Ricezione : 03 Maggio 2022 12:55:49
Data/Ora Inizio
Diffusione presunta
: 03 Maggio 2022 12:55:50
Oggetto : An excellent first quarter with revenue
34%
growth of around 16%. Net profit up over
Testo del comunicato

Vedi allegato.

AN EXCELLENT FIRST QUARTER WITH REVENUE GROWTH OF AROUND 16% AND STRONG IMPROVEMENT IN PROFITABILITY. NET PROFIT UP OVER 34%

REVENUE GROWTH OF AROUND 16% AT CURRENT EXCHANGE RATES AND OF 14% AT CONSTANT EXCHANGE RATES COMPARED TO THE FIRST QUARTER OF 2021, SUPPORTED BY AN EXCELLENT ORGANIC GROWTH, ABOVE THE REFERENCE MARKET

STRONG INCREASE IN RECURRING PROFITABILITY, WITH EBITDA MARGIN 40 BASIS POINTS HIGHER THAN IN THE FIRST QUARTER OF 2021, EVEN AFTER SIGNIFICANT INVESTMENTS IN THE BUSINESS

STRONG CASH GENERATION AND IMPROVEMENT IN THE NET FINANCIAL POSITION OVER DECEMBER 2021, DESPITE SEASONALITY AND AFTER SIGNIFICANT INVESTMENTS IN CAPEX, M&A AND SHARE BUYBACK

NETWORK EXPANSION FUELED BY STRONG M&A ACTIVITY IN CORE MARKETS: CHINA, FRANCE AND GERMANY

CONFIRMED 2022 GUIDANCE PREVIOUSLY ISSUED TO THE MARKET

MAIN RESULTS FOR THE FIRST QUARTER OF 20221

  • Consolidated revenues of 495.8 million euros, an increase at current exchange rates of 15.7% and of 14% at constant exchange rates compared to the first quarter of 2021
  • Recurring EBITDA amounted to 112.9 million euros, an increase of 17.7% compared to the same period of 2021, with the margin rising 40 basis points to 22.8%
  • Recurring net profit was 32.8 million euros, 34.3% higher than in the same period of 2021
  • Free cash flow amounted to 53.4 million euros, higher than in the first quarter of 2021
  • Net financial debt was 868.6 million euros, lower than the 871.2 million euros posted at December 31st, 2021, despite seasonality and after Capex of 21.1 million euros, net cash-out for M&A of 23.8 million euros and share buyback of 29.7 million euros, with financial leverage slightly down to 1.64x at March 31st, 2022

Milan, May 3rd, 2022 – Today the Board of Directors of Amplifon S.p.A. (EXM; Bloomberg ticker: AMP:IM), global leader in hearing solutions and services, approved the Interim Financial Report as at March 31st, 2022 during a meeting chaired by Susan Carol Holland.

As a result of the wind-down of Elite's wholesale business in the United States, finalized in the fourth quarter of 2021, and in accordance with IFRS 5, the income statement figures for the first quarter of 2021 were restated for the exclusion of Elite's discontinued business through the line "Profit (Loss) from Continuing Operations".

ENRICO VITA, CEO

"We have once again begun the year very positively, with revenues and profitability rising sharply compared to the same period of 2021. We outpaced the market, further consolidating our leadership and gaining market share in core countries, a trend we expect will continue for all 2022. The prospects for the hearing care market are positive and the outstanding results achieved in this quarter allow us to look ahead with optimism to both the rest of the year and our Company's medium-term growth prospects".

1 Unless stated otherwise, the comments in this press release refer to the recurring income statement figures

FIRST QUARTER 2022 RESULTS VS 2021

(Euro millions) Q1 2021
Q1 2022
Recurring Non
recurring
Total % on
recurring
Recurring Non
recurring
Total % on
recurring
Change %
on
recurring
Net revenues 495.8 - 495.8 100.0% 428.5 - 428.5 100.0% 15.7%
EBITDA 112.9 (3.0) 109.8 22.8% 95.9 (2.4) 93.5 22.4% 17.7%
EBIT 55.2 (3.0) 52.2 11.1% 42.9 (2.4) 40.5 10.0% 28.5%
Profit (loss) from
continuing
operations
32.9 (2.2) 30.7 6.6% 24.4 (1.8) 22.7 5.7% 34.5%
Net income 32.8 (2.2) 30.6 6.6% 24.4 (1.1) 23.3 5.7% 34.3%
EPS adjusted
(*, in Euro)
0.184 0.144 28.3%
Free cash flow 53.4 52.9
03/31/2022 12/31/2021 Change %
Net Financial
Indebtedness
868.6 871.2 -0.3%

(*) EPS adjusted (adjusted net earnings per share) for non-recurring expenses and for the amortization linked to acquisitions as per the Purchase Price Allocation accounting treatment.

Consolidated revenues amounted to 495.8 million euros in the first quarter of 2022, an increase of 15.7% at current exchange rates and 14.0% at constant exchange rates compared to the first quarter of 2021. This well above market performance is attributable for 8.8% to organic growth and for 5.2% to acquisitions. The foreign exchange effect was positive for 1.7% due mainly to the strengthening of the US dollar against the Euro.

The performance was extremely positive across all regions: an outstanding performance was posted by all the markets in EMEA despite the January peak of Covid-19 contagions and the difficult comparison base in France in March; the AMERICAS was once again the fastest organically growing region thanks to the excellent performance recorded in the United States, Canada and Latin America; APAC reported a positive performance, supported by the Bay Audio acquisition, despite an underlying market impacted by the peak in Covid-19 contagions and related restrictive measures.

Recurring EBITDA was 112.9 million euros, an increase of 17.7% compared to the first quarter of 2021. The margin came in at 22.8%, rising 40 basis points compared to the first quarter of 2021. This significant improvement in profitability is due to the greater operating efficiency and scale, even after significant investments in the business, including in marketing and in the continuation of important strategic initiatives. EBITDA as reported came to 109.8 million euros after non-recurring expenses of 3.0 million euros.

Recurring EBIT came in at 55.2 million euros, 28.5% higher than the 42.9 million euros recorded in the first quarter of 2021, with a margin of 11.1%. EBIT as reported came to 52.2 million euros.

Recurring net profit reached 32.8 million euros, 34.3% higher than in the same period of 2021 thanks to the strong revenue growth and greater operating leverage. Net profit as reported, which reflects the 2.2 million euros in nonrecurring expenses referred to above, amounted to 30.6 million euros. The tax rate came to 29.8%. The adjusted earnings per share (EPS adjusted) came in at 18.4 euro cents, an increase of 28.3% from the 14.4 euro cents reported in the first quarter of 2021.

The Company continued to expand the network in the quarter with the acquisition of 58 shops mainly in France, Germany and China for a total net cash-out of 23.8 million euros. More in detail, Amplifon acquired around 20 shops in China mainly located in the Hubei province. Thanks to this transaction, perfectly aligned to Amplifon's strategy aimed at expanding the Company's presence in this fast-growing market, the total network in China now comprises around 140 points of sale located in the Beijing area, Zhejiang and southeast China, as well as Shanghai and the Hubei province.

Lastly, after the close of the quarter, the Amplifon Product Experience was launched in Switzerland.

PERFORMANCE BY GEOGRAPHIC AREA

EMEA: Excellent top-line growth and step-up in profitability despite the January peak in Covid-19 contagions and challenging comparison base in France at the end of the quarter

(million euros) Q1 2022 Q1 2021 Δ% 22/21
Revenues 340.2 311.1 +9.4%
Organic growth +8.0%
Acquisitions +0.9%
FX +0.5%
EBITDA Rec. 93.5 82.8 +12.8%
Margin % 27.5% 26.6% +90 bps

EMEA posted an excellent performance in revenues, driven mainly by a strong organic growth of 8%, well above the reference market and despite the January peak of Covid-19 contagions. All the Region's markets recorded an outstanding performance, with excellent, double-digit organic growth in Spain, Portugal, the United Kingdom and the Netherlands. A robust performance was also recorded in France, despite the challenging comparison base in March attributable to the regulatory reform.

Profitability was outstanding, with the recurring EBITDA margin coming in at 27.5%, 90 basis points higher than in the same period of 2021, thanks to greater efficiency and scale reached in the core countries.

AMERICAS: another outstanding performance in the United States, driven by an excellent and wellabove market organic growth, and double-digit revenue growth in Canada and Latin America

(million euros) Q1 2022 Q1 2021 Δ% 22/21
Revenues 84.0 64.8 +29.7%
Organic growth +19.6%
Acquisitions +3.0%
FX +7.1%
EBITDA Rec. 20.7 15.7 +31.8%
Margin % 24.6% 24.2% +40 bps

The outstanding revenue performance in the United States was driven by an excellent organic growth of both Miracle-Ear and Amplifon Hearing Health Care, which was more than three times higher than the reference market. Double-digit organic growth was also recorded in Canada and in Latin America. The bolt-on acquisitions made in the United States and Canada contributed for 3.0%, while the exchange effect was positive for 7.1%, mainly due to the noticeable strengthening of the USD against the Euro.

The EBITDA margin came in at 24.6%, 40 basis points higher than in the first quarter of 2021, thanks again to greater efficiency and productivity, even after significant investments in the business.

ASIA-PACIFIC: Strong top-line performance, fostered by Bay Audio contribution, despite a reference market primarily impacted by the peak in Covid-19 contagions

(million euros) Q1 2022 Q1 2021 Δ% 22/21
Revenues 71.5 52.6 +35.7%
Organic growth +0.5%
Acquisitions +33.5%
FX +1.7%
EBITDA Rec. 19.3 15.9 +21.6%
Margin % 27.1% 30.2% -310 bps

ASIA-PACIFIC reported an increase in revenues of 34% at constant exchange rates, driven mainly by the significant contribution of M&A stemming from Bay Audio and the Chinese joint venture. Organic growth was positive despite a soft reference market due to the peak in Covid-19 contagions and related restrictive measures in Australia, New Zealand and China and the floods in Eastern Australia (Queensland and New South Wales) in February.

Recurring EBITDA reached 19.3 million euros, an increase of 21.6% compared to the first quarter of 2021. The EBITDA margin came to 27.1%, lower than in the first quarter of 2021 due to the significant investments in marketing in Australia and the lower operating leverage due to lower than expected organic growth.

BALANCE SHEET FIGURES AS AT MARCH 31ST, 2022

The balance sheet and financial indicators continue to confirm the Group's solidity and the ability to sustain future growth opportunities. In the quarter the Company generated a free cash flow of 53.4 million euros and further strengthened its financial structure.

Total net equity was 979.5 million euros at March 31st, 2022, higher than the 927.3 million euros recorded at December 31st, 2021.

Operating cash flow, before payment of lease liabilities, reached 100.1 million euros. The payment of lease liabilities, equal to 25.6 million euros, brought the operating cash flow to 74.5 million euros, 10% higher than the 67.7 million euros recorded in the first quarter of 2021. Free cash flow came to 53.4 million euros, slightly higher than the 52.9 million euros generated in the first quarter of 2021, after investments (net of disposals) of 21.1 million euros versus 14.8 million euros in the first quarter of 2021. Net cash-out for acquisitions (23.8 million euros versus 32.4 million euros in the first quarter of 2021) and outlays for the share buyback program (29.7 million euros), net of gains on other financial assets of 0.8 million euros, bring the cash flow for the reporting period to a positive 0.7 million euros versus a positive 7.3 million euros in the first quarter of 2021.

Net financial debt came to 868.6 million euros, lower than the 871.2 million euros reported at December 31st, 2021, with financial leverage at 1.64x, compared to 1.68x at December 31st, 2021.

OUTLOOK

The Company expects the hearing care market to grow by around 4-5% in 2022, supported by pent-up demand, which will likely more than offset the expected decline in the French market following its significant structural growth reported in 2021 as a result of the regulatory reform.

In light of the excellent results achieved in the first quarter of 2022, the Company remains positive for the rest of the year and, confirms the previously issued 2022 guidance2 .

Finally, Amplifon remains also confident on its previously disclosed 2023 ambitions while moving fast forward in the execution of its strategic plan.

The Company's 2022 outlook does not include any significant negative impact possibly resulting from the military conflict in Ukraine and assumes no major changes in the evolution of the health emergency and, consequently, no further major disruptions and slowdowns in global economic activity. Lastly, please note that Amplifon has no business activities in Ukraine or Russia.

2 Refer to the press release issued on March 3rd, 2022

ASSIGNMENT OF BENEFICIARIES OF THE PERFORMANCE STOCK GRANT PLAN 2019-2025

In relation to the above-mentioned plan, the Board of Directors resolved to assign 458,500 shares at target on May 3rd, 2022 as the first tranche of the stock grant cycle for the period 2022-2024, based on the recommendations of the Remuneration and Appointments Committee and pursuant to Art. 84 bis, par. 5 of Consob Regulation n. 11971/99, as amended.

The information regarding the beneficiaries and the number of shares assigned will be reported in the table prepared in accordance with the indications provided in Table n. 1, Form 7 of Annex 3A of Regulation n. 11971/1999 and reflecting the characteristics already disclosed in the Information Document, which will be made available within the time period required by law at the Company's registered office and published on the Company's website https://corporate.amplifon.com.

The Information Document relating to the new Stock Grant Plan 2019-2025, which contains all the detailed information required by current law, is available to the public in the same manner.

SUSTAINABLE VALUE SHARING PLAN 2022-2027

With reference to the Sustainable Value Sharing Plan 2022-2027 reserved to the CEO/General Manager (the "Scheme"), the Board of Directors resolved to assign a total number of rights equal to a maximum of 48,000, based on the recommendations of the Remuneration and Appointments Committee and pursuant to Art. 84 bis, par. 5 of Consob Regulation n. 11971/99.

It should be noted that the amount of rights that will be effectively assigned, pursuant to the Plan, will depend on the beneficiary's election mechanisms provided by the Scheme itself, as described in the Information Document approved by the Shareholders' Meeting on April 22nd, 2022.

The information regarding the number of rights effectively assigned will be set out in the table prepared in accordance with the indications contained in Table 1, Schedule 7 of Annex 3A of Consob Regulation n. 11971/1999, which will be available within the terms and according to the procedures required by law.

It should be noted that, the Interim Report as at 31 March 2022 will be made available to the public as from 11 May 2022 at the Company's registered office, on the Company's website at https://corporate.amplifon.com and at the authorized storage mechanism eMarket STORAGE ().

*****

The results for the first quarter of 2022 will be presented today at 15:00 CET during a conference call and audiowebcast with the financial community. To participate in the conference call dial one of the following numbers: +44 121 281 8004 (UK), +1 718 705 8796 (USA), +33 170918704 (France) or +39 02 802 09 11 (Italy). Otherwise, you can participate in the audiowebcast by accessing the following link:

*****

https://services.choruscall.com/mediaframe/webcast.html?webcastid=ijjMJDgW

Before the beginning of the conference call, starting from 2:30 p.m. (CET), a few presentation slides will be made available on the website https://corporate.amplifon.com, in the Investors section (Presentations). Those who are not able to attend the conference call may access a recording which will be available immediately after the call until 24:00 (CET) of May 6th , 2022, by dialing the following number: +39 02 802 0987 (Italy), access code: 905# - guest code: 700905#, or, at the end of the listening period, by accessing the webpage:

https://corporate.amplifon.com/en/investors/financial-calendar/results-presentation-q1-2022

In compliance with paragraph 2 of Article 154 bis of the "Uniform Financial Services Act" (Legislative Decree 58/1998), the Manager charged with preparing the Company's financial reports, Gabriele Galli, declares that the accounting information reported in the present press release corresponds to the underlying documentary reports, books of account and accounting entries.

*****

*****

Any differences in the totals reported in the tables in this press release may be due to rounding.

*****

This press release contains forward-looking statements. These statements are based on the Company's current expectations and projections about future events and, by their nature, are subject to inherent risks and uncertainties.

They relate to events and depend on circumstances that may or may not occur or exist in the future, and, as such, undue reliance should not be placed on them. Actual results may differ materially from those expressed in such statements as a result of a variety of factors, including: continued volatility and further deterioration of capital and financial markets, changes in general macro-economic conditions, economic growth and other changes in business conditions, changes in laws and regulations (both in Italy and abroad), and many other factors, most of which are outside of the Company's control.

About Amplifon

Amplifon, global leader in the hearing care retail market, empowers people to rediscover all the emotions of sound. Amplifon's around 18,600 people worldwide strive every day to understand the unique needs of every customer, delivering exclusive, innovative and highly personalized products and services, to ensure everyone the very best solution and an outstanding experience. The Group operates through a network of over 9,200 points of sale in 25 Countries and 5 continents. More information about the Group is available at: https://corporate.amplifon.com.

Investor Relations

Amplifon S.p.A. Francesca Rambaudi Tel +39 02 5747 2261 [email protected]

Media Relations

Brunswick Massimo Gaia / Barbara Scalchi Tel +39 02 9288 6200 [email protected]

Corporate Communication

Amplifon S.p.A. Luca Marini Tel +39 02 5747 2005 [email protected]

CONSOLIDATED NET REVENUES BY GEOGRAPHIC AREA – Q1 2022 VS Q1 2021

(€ thousands) Q1 2022 % Q1 2021 % Change Change
%
Exchange
diff.
Change %
in local
currency
Organic
growth %
(*)
Total EMEA 340,172 68.6% 311,084 72.6% 29,088 9.4% 1,645 8.8% 8.0%
Total Americas 84,021 16.9% 64,782 15.1% 19,239 29.7% 4,619 22.6% 19.6%
Total APAC 71,462 14.5% 52,647 12.3% 18,815 35.7% 903 34.0% 0.5%
Corporate and intercompany
elimination
153 - - - 153 n.a. - n.a. -
Total 495,808 100.0% 428,513 100.0% 67,295 15.7% 7,167 14.0% 8.8%

(*) Organic growth is calculated as sum of same store growth and openings.

CONSOLIDATED INCOME STATEMENT – FIRST QUARTER 2022 VS FIRST QUARTER 2021

(€ thousands) Q1 2022 Q1 2021
Recurring Non
recurring
Total % on
recurring
Recurring Non
recurring
Total % on
recurring
Change %
on
recurring
Revenues from sales and
services
495,808 - 495,808 100.0% 428,513 - 428,513 100.0% 15.7%
Operating costs (384,518) (2,996) (387,514) -77.6% (335,270) (2,405) (337,675) -78.2% -14.7%
Other income and costs 1,563 (51) 1,512 0.3% 2,675 - 2,675 0.6% -41.6%
Gross operating profit
(EBITDA)
112,853 (3,047) 109,806 22.8% 95,918 (2,405) 93,513 22.4% 17.7%
Depreciation, amortization
and impairment of non
current assets
(20,022) - (20,022) -4.1% (19,226) - (19,226) -4.5% -4.1%
Right-of-use depreciation (26,117) - (26,117) -5.3% (23,185) - (23,185) -5.4% -12.6%
Operating result before the
amortization and
impairment of PPA related
assets (EBITA)
66,714 (3,047) 63,667 13.5% 53,507 (2,405) 51,102 12.5% 24.7%
PPA related depreciation,
amortization and impairment
(11,510) - (11,510) -2,4% (10,559) - (10,559) -2.5% -9.0%
Operating profit (EBIT) 55,204 (3,047) 52,157 11,1% 42,948 (2,405) 40,543 10.0% 28.5%
Income, expenses, valuation
and adjustments of financial
assets
49 - 49 0,0% (14) - (14) 0.0% n.s.
Net financial expenses (8,257) - (8,257) -1,8% (7,162) - (7,162) -1.6% -15.3%
Exchange differences and
non-hedge accounting
instruments
(236) - (236) 0.0% (337) - (337) -0.1% 30.0%
Profit (loss) before tax 46,760 (3,047) 43,713 9.4% 35,435 (2,405) 33,030 8.3% 32.0%
Tax (13,879) 853 (13,026) -2.8% (10,990) 645 (10,345) -2.6% -26.3%
Profit (loss) from continuing
operations
32,881 (2,194) 30,687 6.6% 24,445 (1,760) 22,685 5.7% 34.5%
Profit (loss) from discontinued
operations
- - - 0.0% - 612 612 0.0% -
Net profit (loss) 32,881 (2,194) 30,687 6.6% 24,445 (1,148) 23,297 5.7% 34.5%
Profit (loss) of minority
interests
74 - 74 0.0% 24 - 24 0.0% 208.3%
Net profit (loss) attributable
to the Group
32,807 (2,194) 30,613 6.6% 24,421 (1,148) 23,273 5.7% 34.3%

NON-RECURRING ITEMS – FIRST QUARTER 2022

(€ thousands) Q1
2022
Q1
2021
GAES integration costs (1,047) (1,439)
Charitable donation costs (1,000) -
Bay Audio integration costs (1,000) -
Amplifon S.p.A. restructuring costs - (966)
Impact of the non-recurring items on EBITDA (3,047) (2,405)
Impact of the non-recurring items on EBIT (3,047) (2,405)
Impact of the non-recurring items on profit before tax (3,047) (2,405)
Impact of the above items on the tax burden for the period 853 645
Impact of the non-recurring items on net profit (2,194) (1,760)
Profit (loss) from discontinued operations - 612
Impact of the non-recurring items on net profit (2,194) (1,148)

CONSOLIDATED SEGMENT INFORMATION – Q1 2022 VS Q1 2021

(€ thousands) Q1 2022 Q1 2021
EMEA Americas Asia
Pacific
Corporate
(*)
Total EMEA Americas Asia
Pacific
Corporate
(*)
Total
Net Revenues 340,172 84,021 71,462 153 495,808 311,084 64,782 52,647 - 428,513
EBITDA 92,410 20,670 18,331 (21,605) 109,806 81,395 15,688 15,892 (19,462) 93,513
% on sales 27.2% 24.6% 27.1% -4.6% 22.1% 26.2% 24.2% 30.2% -4.5% 21.8%
Recurring
EBITDA
93,457 20,670 19,331 (20,605) 112,853 82,833 15,688 15,892 (18,495) 95,918
% on sales 27.5% 24.6% 27.1% -4.2% 22.8% 26.6% 24.2% 30.2% -4.3% 22.4%
EBIT 56,315 15,583 7,847 (27,588) 52,157 44,341 10,363 8,573 (22,734) 40,544
% on sales 16.6% 18.5% 11.0% -5.6% 10.5% 14.3% 16.0% 16.3% -5.3% 9.5%

(*) The impact of the centralized costs is calculated as a percentage of the Group's total sales.

RECLASSIFIED CONSOLIDATED BALANCE SHEET

(€ thousands) 03/31/2022 12/31/2021 Change
Goodwill 1,734,977 1,681,470 53,507
Customer lists, non-compete agreements, trademarks and location rights 286,214 284,592 1,622
Software, licenses, other int.ass., wip and advances 130,771 129,938 833
Tangible assets 190,834 186,845 3,989
Right of use assets 453,615 437,377 16,238
Fixed financial assets 10,512 11,923 (1,411)
Other non-current financial assets 41,492 40,436 1,056
Total fixed assets 2,848,415 2,772,581 75,834
Inventories 68,481 62,570 5,911
Trade receivables 172,876 168,680 4,196
Other receivables 97,191 96,761 430
Current assets (A) 338,548 328,011 10,537
Total assets 3,186,963 3,100,592 86,371
Trade payables (257,000) (242,507) (14,493)
Other payables (387,000) (377,394) (9,606)
Provisions for risks (current portion) (2,470) (3,282) 812
Short term liabilities (B) (646,470) (623,183) (23,287)
Working capital (A) – (B) (307,922) (295,172) (12,750)
Derivative instruments 4,902 (3,447) 8,349
Deferred tax assets 86,926 85,185 1,741
Deferred tax liabilities (107,167) (105,191) (1,976)
Provisions for risks (non-current portion) (26,626) (29,079) 2,453
Employee benefits (non-current portion) (20,442) (20,763) 321
Loan fees 6,458 7,017 (559)
Other long-term payables (166,698) (160,733) (5,965)
NET INVESTED CAPITAL 2,317,846 2,250,398 67,448
Shareholders' equity 977,342 925,178 52,164
Third parties' equity 2,190 2,103 87
Net equity 979,532 927,281 52,251
Long term net financial debt 1,011,470 1,023,780 (12,310)
Short term net financial debt (142,899) (152,594) 9,695
Total net financial debt 868,571 871,186 (2,615)
Lease liabilities 469,743 451,931 17,812
Total lease liabilities & net financial debt 1,338,314 1,323,117 15,197
NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL DEBT 2,317,846 2,250,398 67,448

CONSOLIDATED NET FINANCIAL DEBT MATURITY PROFILE

(€ millions) 2022 2023 2024 2025 2026
& beyond
Total
Private placement - (46.6) - (38.8) (85.4)
Eurobond - - - - (350.0) (350.0)
Bank loans (80.2) (116.8) (225.0) (122.1) (105.0) (649.1)
Financing for GAES acquistion - - - - -
Bank accounts (52.5) - - - (52.5)
Other (3.4) (19.4) (1.1) - (23.9)
Short term investments 50.3 - - - 50.3
Cash and acash equivalents 241.9 - - - 241.9
Total 156.2 (182.8) (226.0) (160.9) (455.0) (868.6)

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

(€ thousands) Q1 2022 (*) Q1 2021 (**)
EBIT 52,157 41,175
Amortization, depreciation and write-downs 57,649 52,978
Provisions, other non-monetary items and gain/losses from disposals 2,869 3,133
Net financial expenses (7,920) (6,728)
Taxes paid (6,693) (7,016)
Changes in net working capital 2,015 7,098
Cash flow provided by (used in) operating activities before repayment of lease
liabilities
100,077 90,640
Repayment of lease liabilities (25,587) (22,950)
Cash flow provided by (used in) operating activities (A) 74,490 67,690
Cash flow provided by (used in) operating investing activities (B) (21,080) (14,833)
Free Cash Flow (A) + (B) 53,410 52,857
Net cash flow provided by (used in) acquisitions (C) (23,855) (35,228)
(Purchase) sale of other investment, securities and business units (D) 40 2,878
Cash flow provided by (used in) investing activities (B+C+D) (44,895) (47,183)
Cash flow provided by (used in) operating activities and investing activities 29,595 20,507
Fees paid on medium/long-term financing - -
Treasury shares (29,723) (13,331)
Capital increases, third parties' contributions and dividends paid by subsidiaries to
third parties
- 5
Hedging instruments and other changes in non-current assets 816 165
Net cash flow from the period 688 7,346
Net financial indebtedness as of period opening date (871,186) (633,665)
Effect of exchange rate fluctuations on financial position 1,927 894
Change in net financial position 688 7,346
Net financial indebtedness as of period closing date (868,571) (625,425)

(*) Cash flow is negatively impacted by non-recurring items for Euro 1,953 thousand. (**) Cash flow is negatively impacted by non-recurring items for Euro 2.223 thousand.